Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/308% below fair value
$317.54+6.82 (+2.19%)
Close on Nov 17, 2026Market cap $120.89BP/E 33.8Yield –
Stryker EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Stryker's EPS for the twelve months ending Sep 30, 2026 was $9.39, up 23.4% year over year. For fiscal 2025 it was $8.40, up 8.2% from the year before. Over ten years it grew 8.3% a year on average. The highest annual figure on record is $9.34 in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.40 | +8.2% |
| FY2024 | Dec 31, 2024 | $7.76 | -5.9% |
| FY2023 | Dec 31, 2023 | $8.25 | +33.7% |
| FY2022 | Dec 31, 2022 | $6.17 | +18.4% |
| FY2021 | Dec 31, 2021 | $5.21 | +24.0% |
| FY2020 | Dec 31, 2020 | $4.20 | -23.4% |
| FY2019 | Dec 31, 2019 | $5.48 | -41.3% |
| FY2018 | Dec 31, 2018 | $9.34 | +248.5% |
| FY2017 | Dec 31, 2017 | $2.68 | -38.4% |
| FY2016 | Dec 31, 2016 | $4.35 | +15.1% |
| FY2015 | Dec 31, 2015 | $3.78 | +182.1% |
| FY2014 | Dec 31, 2014 | $1.34 | -49.0% |
| FY2013 | Dec 31, 2013 | $2.63 | -22.4% |
| FY2012 | Dec 31, 2012 | $3.39 | -1.7% |
| FY2011 | Dec 31, 2011 | $3.45 | +8.2% |
| FY2010 | Dec 31, 2010 | $3.19 | +15.2% |
| FY2009 | Dec 31, 2009 | $2.77 | -0.4% |
| FY2008 | Dec 31, 2008 | $2.78 | +13.9% |
| FY2007 | Dec 31, 2007 | $2.44 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.96 | -11.7% |
| Q2 FY2026 | Jun 30, 2026 | $3.30 | +44.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.93 | +14.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.20 | +56.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.22 | +2.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.29 | +7.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.69 | -17.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.41 | -52.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.16 | +20.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.14 | +10.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.05 | +33.1% |
| Q4 FY2023 | Dec 31, 2023 | $2.98 | +102.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.80 | -15.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.93 | +12.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.54 | +83.3% |
| Q4 FY2022 | Dec 31, 2022 | $1.47 | -15.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.14 | +87.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.72 | +11.0% |
| Q1 FY2022 | Mar 31, 2022 | $0.84 | +6.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.73 | +16.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.14 | -30.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.55 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.79 | -39.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.49 | -21.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.63 | +32.5% |
| Q2 FY2020 | Jun 30, 2020 | -$0.22 | -117.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.30 | +19.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.90 | -65.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.23 | -20.6% |
| Q2 FY2019 | Jun 30, 2019 | $1.26 | +5.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.09 | -6.0% |
| Q4 FY2018 | Dec 31, 2018 | $5.44 | – |
| Q3 FY2018 | Sep 30, 2018 | $1.55 | +36.0% |
| Q2 FY2018 | Jun 30, 2018 | $1.19 | +15.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.16 | -0.9% |
| Q4 FY2017 | Dec 31, 2017 | -$0.66 | -149.3% |
| Q3 FY2017 | Sep 30, 2017 | $1.14 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.03 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.17 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.34 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?